Krtap10-4 is a gene that has been newly associated with major adverse cardiovascular events (MACE). However, the provided abstract does not detail its essential function, associated pathways, or overall biological importance. Genetic models could potentially be valuable in further exploring these aspects of Krtap10-4.

A study identified Krtap10-4 (rs201441480) as one of eight new genotypes and their associated genes related to MACE in patients with acute coronary syndromes (ACS). This discovery was made through a two-stage large-scale sequencing data analysis, including high-depth whole exome sequencing in a discovery cohort and high-depth targeted sequencing in a replication cohort [1].

In conclusion, while the exact biological functions of Krtap10-4 are yet to be fully elucidated, its association with MACE in ACS patients discovered through genetic sequencing in this study indicates its potential importance in cardiovascular-related disease areas. Further in vivo studies, such as gene knockout (KO) or conditional knockout (CKO) mouse models, could be used to better understand its role in these disease processes. [1]

References:

1. Liu, Xiaomin, Xu, Hanshi, Xu, Huaiqian, Liu, Xiao, Zhong, Shilong. 2021. New genetic variants associated with major adverse cardiovascular events in patients with acute coronary syndromes and treated with clopidogrel and aspirin. In The pharmacogenomics journal, 21, 664-672. doi:10.1038/s41397-021-00245-5. https://pubmed.ncbi.nlm.nih.gov/34158603/